Researchers have revealed the cellular mysteries behind aging.
Researchers have revealed the cellular mysteries behind aging.
University of Maryland bioengineers have developed a new technique to capture and analyze circulating tumor cells, one of the primary culprits in metastatic cancer.
WORCESTER, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc.(Mustang) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating todays medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that the first patient successfully received LV-RAG1 ex vivo lentiviral gene therapy to treat recombinase-activating gene-1 (RAG1) severe combined immunodeficiency (RAG1-SCID), in an ongoing Phase 1/2 multicenter clinical trial taking place in Europe. LV-RAG1 is exclusively licensed by Mustang for the development of MB-110, a first-in-class ex vivo lentiviral gene therapy for the treatment of RAG1-SCID. Patients with SCID have mutations in blood stem cell genes that are responsible for the development and function of infection-fighting immune cells.
DUBLIN, July 25, 2022 /PRNewswire/ -- The 'Global Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western Blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End-user (Pharma, Biotech, CROs), and Region - Forecast to 2027'report has been added to ResearchAndMarkets.com's offering. Research and Markets Logo The global research antibodies and reagents market is projected to reach USD 16.1 billion by 2027 from USD 11.6 billion in 2022, at a CAGR of 6.7% The research antibodies and reagents market evolved owing to factors such as increasing proteomics and genomics research, growing demand for antibodies for research reproducibility, and increasing R&D expenditure in the life sciences industry
According to this report, Stem Cell And Regenerative Therapy Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information.
Ms. DuRossbrings more than 25 years' experience to her new position. Prior to joining CSafe, she was the co-founder and CEO of Vineti, an enterprise software platform used to digitize chain of identity and chain of custody requirements for CGT products
Loren and Mike Gordon. Image by Sonya Yruel A personal investigation into the lifelong implications of his type 1 diabetes (T1D) culminated in a $7 million gift from Mike Gordon, co-founder of Meritech Capital Partners, and his wife, Loren, to help UCSF surmount a key impediment to treating the disease
SAN FRANCISCO, July 21, 2022 /PRNewswire/ -- The global cell culture media market size is expected to reach USD 10.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.1% from 2022 to 2030.
Wilmington, Delaware, United States, July 18, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc.: The market value of the global cell separation technologies market is estimated to be over US$ 20.3 Bn by 2031, according to a research report by Transparency Market Research (TMR).
Autologous Stem Cell and Non-Stem Cell Based Therapies Marketbusiness report provides detailed information on important aspects such as drivers and constraints that define the future growth of the market. This business report includes both qualitative and quantitative aspects of the industry in each region and country mentioned in the market research study
Recent Comments